Outcomes of patients treated with triple antithrombotic therapy after primary percutaneous coronary intervention for st-elevation myocardial infarction (from the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-AMI] trial)

American Journal of Cardiology

Volumn 109, Issue 6, 2012, Pages 831-838

  Nikolsky, Eugenia ^a,b   Mehran, Roxana ^b,c   Dangas, George D ^b,c   Yu, Jennifer ^c   Parise, Helen ^b   Xu, Ke ^b   Pocock, Stuart J ^d   Stone, Gregg W ^b,e  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^c MOUNT SINAI MEDICAL CENTER   (United States)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e New York Presbyterian Morgan Stanley Children's Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIVITAMIN K; CLOPIDOGREL; HEPARIN; HIRULOG; THIENOPYRIDINE DERIVATIVE; TICLOPIDINE;

ADULT; AGE; AGED; ARTICLE; BARE METAL STENT; BLEEDING; DISEASE SEVERITY; DRUG DOSE TITRATION; DRUG ELUTING STENT; DRUG WITHDRAWAL; ECCHYMOSIS; EPISTAXIS; FEMALE; GASTROINTESTINAL HEMORRHAGE; GENDER; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE CONDUCTION DISTURBANCE; HEART MUSCLE ISCHEMIA; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT; THROMBUS; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, BALLOON, CORONARY; ASPIRIN; CORONARY ANGIOGRAPHY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; DRUG-ELUTING STENTS; ELECTROCARDIOGRAPHY; FEMALE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POSTOPERATIVE PERIOD; PROSPECTIVE STUDIES; PYRIDINES; TREATMENT OUTCOME;

EID: 84857791763     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2011.10.046     Document Type: Article

References (30)

1. P. Smith, H. Arnesen, I. Holme The effect of warfarin on mortality and reinfarction after myocardial infarction N Engl J Med 323 1990 147 152 (Pubitemid 20219942)
2. E.M. Antman, D.T. Anbe, P.W. Armstrong, E.R. Bates, L.A. Green, M. Hand, J.S. Hochman, H.M. Krumholz, F.G. Kushner, G.A. Lamas, C.J. Mullany, J.P. Ornato, D.L. Pearle, M.A. Sloan, S.C. Smith Jr, J.S. Alpert, J.L. Anderson, D.P. Faxon, V. Fuster, R.J. Gibbons, G. Gregoratos, J.L. Halperin, L.F. Hiratzka, S.A. Hunt, A.K. Jacobs American College of Cardiology, American Heart Association Task Force on Practice Guidelines, Canadian Cardiovascular Society ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction) Circulation 110 2004 e82 e292
3. R. Sørensen, M.L. Hansen, S.Z. Abildstrom, A. Hvelplund, C. Andersson, C. Jørgensen, J.K. Madsen, P.R. Hansen, L. Køber, C. Torp-Pedersen, G.H. Gislason Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data Lancet 374 2009 1967 1974
4. R. Mehran, B. Brodie, D.A. Cox, C.L. Grines, B. Rutherford, D.L. Bhatt, G. Dangas, F. Feit, E.M. Ohman, H. Parise, M. Fahy, A.J. Lansky, G.W. Stone The Harmonizing Outcomes with revascularization and Stents in acute myocardial infarction (HORIZONS-AMI) Trial: Study design and rationale Am Heart J 156 2008 44 56 (Pubitemid 351862292)
5. G.W. Stone, B. Witzenbichler, G. Guagliumi, J.Z. Peruga, B.R. Brodie, D. Dudek, R. Kornowski, F. Hartmann, B.J. Gersh, S.J. Pocock, G. Dangas, S.C. Wong, A.J. Kirtane, H. Parise, R. Mehran HORIZONS-AMI Trial Investigators Bivalirudin during primary PCI in acute myocardial infarction N Engl J Med 358 2008 2218 2230 (Pubitemid 351724451)
6. G.W. Stone, A.J. Lansky, S.J. Pocock, B.J. Gersh, G. Dangas, S.C. Wong, B. Witzenbichler, G. Guagliumi, J.Z. Peruga, B.R. Brodie, D. Dudek, M. Mckel, A. Ochala, A. Kellock, H. Parise, R. Mehran HORIZONS-AMI Trial Investigators Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction N Engl J Med 360 2009 1946 1959
7. E.A. Loeliger, A. Hensen, F. Kroes, L.M. van Dijk, N. Fekkes, H. de Jonge, H.C. Hemker A double-blind trial of long-term anticoagulant treatment after myocardial infarction Acta Med Scand 182 1967 549 566
8. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2 Lancet 2 1988 349 360
9. S. Yusuf, F. Zhao, S.R. Mehta, S. Chrolavicius, G. Tognoni, K.K. Fox Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 2001 494 502 (Pubitemid 32758501)
10. M.B. Leon, D.S. Baim, J.J. Popma, P.C. Gordon, D.E. Cutlip, K.K. Ho, A. Giambartolomei, D.J. Diver, D.M. Lasorda, D.O. Williams, S.J. Pocock, R.E. Kuntz A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting Stent Anticoagulation restenosis Study Investigators N Engl J Med 339 1998 1665 1671 (Pubitemid 28550691)
11. M.E. Bertrand, H.J. Rupprecht, P. Urban, A.H. Gershlick CLASSICS Investigators Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting: the clopidogrel aspirin stent international cooperative study (CLASSICS) Circulation 102 2000 624 629 (Pubitemid 30640661)
12. P.P. Karjalainen, P. Porela, A. Ylitalo, S. Vikman, K. Nyman, M.A. Vaittinen, T.J. Airaksinen, M. Niemel, T. Vahlberg, K.E. Airaksinen Safety and efficacy of combined antiplatelet-warfarin therapy after coronary stenting Eur Heart J 28 2007 726 732 (Pubitemid 46439228)
13. ACTIVE Writing Group of the ACTIVE Investigators S. Connolly, J. Pogue, R. Hart, M. Pfeffer, S. Hohnloser, S. Chrolavicius, M. Pfeffer, S. Hohnloser, S. Yusuf, S. Yusuf Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the atrial fibrillation clopidogrel Trial with irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial Lancet 367 2006 1903 1912
14. APEX AMI Investigators P.W. Armstrong, C.B. Granger, P.X. Adams, C. Hamm, D. Holmes Jr, W.W. O'Neill, T.G. Todaro, A. Vahanian, F. Van de Werf Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial JAMA 297 2007 43 51 (Pubitemid 46041725)
15. R.D. Lopes, L.E. Elliott, H.D. White, J.S. Hochman, F. Van de Werf, D. Ardissino, T.T. Nielsen, W.D. Weaver, P. Widimsky, P.W. Armstrong, C.B. Granger Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trial Eur Heart J 30 2009 2019 2028
16. S. Solheim, I. Seljeflot, K. Lunde, R. Bjørnerheim, S. Aakhus, K. Forfang, H. Arnesen Frequency of left ventricular thrombus in patients with anterior wall acute myocardial infarction treated with percutaneous coronary intervention and dual antiplatelet therapy Am J Cardiol 106 2010 1197 1200
17. M. Maeng, P.H. Nielsen, M. Busk, L.S. Mortensen, S.D. Kristensen, T.T. Nielsen, H.R. Andersen DANAMI-2 Investigators Time to treatment and three-year mortality after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction-a DANish Trial in Acute Myocardial Infarction-2 (DANAMI-2) substudy Am J Cardiol 105 2010 1528 1534
18. G.W. Stone, C.L. Grines, D.A. Cox, E. Garcia, J.E. Tcheng, J.J. Griffin, G. Guagliumi, T. Stuckey, M. Turco, J.D. Carroll, B.D. Rutherford, A.J. Lansky Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Investigators Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction N Engl J Med 346 2002 957 966 (Pubitemid 34983245)
19. M.A. Vink, M.T. Dirksen, M.J. Suttorp, J.G. Tijssen, J. van Etten, M.S. Patterson, T. Slagboom, F. Kiemeneij, G.J. Laarman 5-Year follow-up after primary percutaneous coronary intervention with a paclitaxel-eluting stent versus a bare-metal stent in acute ST-segment elevation myocardial infarction: a follow-up study of the PASSION (Paclitaxel-Eluting Versus Conventional Stent in Myocardial Infarction with ST-Segment Elevation) trial JACC Cardiovasc Interv 4 2011 24 29
20. C. Spaulding, E. Teiger, P. Commeau, O. Varenne, E. Bramucci, M. Slama, K. Beatt, A. Tirouvanziam, L. Polonski, P.R. Stella, R. Clugston, J. Fajadet, X. de Boisgelin, C. Bode, D. Carri, A. Erglis, B. Merkely, S. Hosten, A. Cebrian, P. Wang, H.P. Stoll, P. Henry Four-year follow-up of TYPHOON (trial to assess the use of the CYPHer sirolimus-eluting coronary stent in acute myocardial infarction treated with BallOON angioplasty) JACC Cardiovasc Interv 4 2011 14 23
21. B. Brodie, Y. Pokharel, N. Fleishman, A. Bensimhon, G. Kissling, C. Hansen, S. Milks, M. Cooper, C. McAlhany, T. Stuckey Very late stent thrombosis after primary percutaneous coronary intervention with bare-metal and drug-eluting stents for ST-segment elevation myocardial infarction: a 15-year single-center experience JACC Cardiovasc Interv 4 2011 30 38
22. Z.M. Younossi, W.B. Strum, R.A. Schatz, P.S. Teirstein, D.A. Cloutier, T.J. Spinks Effect of combined anticoagulation and low-dose aspirin treatment on upper gastrointestinal bleeding Dig Dis Sci 42 1997 79 82 (Pubitemid 27059925)
23. S.J. Mattichak, P.S. Reed, M.J. Gallagher, J.A. Boura, W.W. O'Neill, J.K. Kahn Evaluation of safety of warfarin in combination with antiplatelet therapy for patients treated with coronary stents for acute myocardial infarction J Interv Cardiol 18 2005 163 166 (Pubitemid 40942726)
24. C.L. Campbell, S. Smyth, G. Montalescot, S.R. Steinhubl Aspirin dose for the prevention of cardiovascular disease: a systematic review JAMA 297 2007 2018 2024 (Pubitemid 46740354)
25. E. Nikolsky, G.W. Stone, A.J. Kirtane, G.D. Dangas, A.J. Lansky, B. McLaurin, A.M. Lincoff, F. Feit, J.W. Moses, M. Fahy, S.V. Manoukian, H.D. White, E.M. Ohman, M.E. Bertrand, D.A. Cox, R. Mehran Gastrointestinal bleeding in patients with acute coronary syndromes: incidence, predictors and clinical implications: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial J Am Coll Cardiol 54 2009 1293 1302
26. G.Y. Lip, F. Andreotti, L. Fauchier, K. Huber, E. Hylek, E. Knight, D.A. Lane, M. Levi, F. Marin, G. Palareti, P. Kirchhof, J.P. Collet, A. Rubboli, D. Poli, J. Camm Document reviewers: Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis Europace 13 2011 723 746
27. V. Fuster, L.E. Rydn, D.S. Cannom, H.J. Crijns, A.B. Curtis, K.A. Ellenbogen, J.L. Halperin, G.N. Kay, J.Y. Le Huezey, J.E. Lowe, S.B. Olsson, E.N. Prystowsky, J.L. Tamargo, L.S. Wann 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in partnership with the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society J Am Coll Cardiol 57 2011 e101 e198
28. S.D. Wiviott, E. Braunwald, C.H. McCabe, G. Montalescot, W. Ruzyllo, S. Gottlieb, F.J. Neumann, D. Ardissino, S. De Servi, S.A. Murphy, J. Riesmeyer, G. Weerakkody, C.M. Gibson, E.M. Antman TRITON-TIMI 38 Investigators Prasugrel versus clopidogrel in patients with acute coronary syndromes N Engl J Med 357 2007 2001 2015 (Pubitemid 350106708)
29. L. Wallentin, R.C. Becker, A. Budaj, C.P. Cannon, H. Emanuelsson, C. Held, J. Horrow, S. Husted, S. James, H. Katus, K.W. Mahaffey, B.M. Scirica, A. Skene, P.G. Steg, R.F. Storey, R.A. Harrington, A. Freij, M. Thorsn PLATO Investigators Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med 361 2009 1045 1057
30. L. Wallentin, S. Yusuf, M.D. Ezekowitz, M. Alings, M. Flather, M.G. Franzosi, P. Pais, A. Dans, J. Eikelboom, J. Oldgren, J. Pogue, P.A. Reilly, S. Yang, S.J. Connolly RE-LY Investigators Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial Lancet 376 2010 975 983